New patent for Abbvie Inc drug MAVYRET

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. The generic ingredient in…

The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch Blog.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: